Skip to main content
SpringerLink
Log in

Clinical Implications of the Pharmacokinetics of Tricyclic Antidepressants

  • Conference paper
Clinical Pharmacology in Psychiatry

Part of the book series: Psychopharmacology Series ((PSYCHOPHARM,volume 7))

Abstract

Knowledge gained during the past 20 years about the pharmacokinetics of tricyclic antidepressant drugs has helped to refine clinical practice. This discussion will focus on kinetic features of tricyclic antidepressants which appear to have important implications for clinical practice.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Amsterdam JD, Brunswick DJ, Potter L et al. (1985) Desipramine and 2-hydroxy-desipramine plasma levels in endogenous depressed patients: lack of correlation with therapeutic response. Arch Gen Psychiatry 42: 361–364

    PubMed  CAS  Google Scholar 

  • APA Task Force on the Use of Laboratory Tests in Psychiatry (1985) Tricyclic antidepressants - blood level measurements and clinical outcome: an APA task force report. Am J Psychiatry 142: 155–162

    Google Scholar 

  • Asberg M, Chronholm B, Sjoqvist F et al. (1970) Correlation of subjective side effects with plasma concentration of nortriptyline. Br Med J 4: 18–21

    Article  PubMed  CAS  Google Scholar 

  • Bertilsson L, Mellstrom B, Sjoqvist F (1979) Pronounced inhibition of noradrenaline uptake by 10-hydroxy-metabolites of nortriptyline. Life Sci 25: 1285–1292

    Article  PubMed  CAS  Google Scholar 

  • Bjerre M, Gram LF, Kragh-Sorensen P et al. (1981) Dose-dependent kinetics of imipramine in elderly patients. Psychopharmacology (Berlin) 75: 354–357

    Article  CAS  Google Scholar 

  • Bock JL, Giller E, Gray S et al. (1982) Steady-state plasma concentrations of cis and trans-lO-OH amitriptyline metabolites. Clin Pharmacol Ther 31: 609–616

    Article  PubMed  CAS  Google Scholar 

  • Bock JL, Nelson JC, Gray S et al. (1983) Desipramine hydroxylation: variability and effect of antipsychotic drags. Clin Pharmacol Ther 33: 190–197

    Article  Google Scholar 

  • Breyer-Pfaff U, Gaertner HJ, Kreuter F et al. (1982) Antidepressive effect and pharmacokinetics of amitriptyline with consideration of unbound drag and 10- hydroxynortriptyline plasma levels. Psychopharmacology (Berlin) 76: 240–244

    Article  CAS  Google Scholar 

  • Brosen K, Gram LF, Klysner R, Bech P (1986) Steady-state levels of imipramine and its metabolites: significance of dose-dependent kinetics. Eur J Clin Pharmacol 30: 43–49

    Article  PubMed  CAS  Google Scholar 

  • Cooke RG, Warsh J J, Stancer HC et al. (1984) The nonlinear kinetics of desipramine and 2-hydroxydesipramine in plasma. Clin Pharmacol Ther 36: 343–349

    Article  PubMed  CAS  Google Scholar 

  • Dawling S, Ford S, Rangedara DC, Lewis RR (1984) Amitriptyline dosage prediction in elderly patients from plasma concentration at 24 hours after a single 100 mg dose. Clin Pharmacokinet 9: 261–266

    Article  PubMed  CAS  Google Scholar 

  • Gram LF, Overo KF (1972) Drag interaction: inhibitory effect of neuroleptics on metabolism of tricyclic antidepressants in man. Br Med J 1: 463–465

    Article  PubMed  CAS  Google Scholar 

  • Javaid JI, Matuzas W, Davis JM, Fawcett J (1985) Plasma protein binding of tricyclic antidepressants in young and elderly. Presented at the American College of Neuro-psychopharmacology, Annual Meeting, December 1985

    Google Scholar 

  • Kitanaka I, Ross RJ, Cutler NR et al. (1982) Altered hydroxydesipramine concentrations in elderly depressed patients. Clin Pharmacol Ther 31: 51–55

    Article  PubMed  CAS  Google Scholar 

  • Kutcher SP, Reid K, Dubbin JD et al. (1986a) Electrocardiogram changes and therapeutic desipramine and 2-hydroxy-desipramine concentrations in elderly depressives. Br J Psychiatry 148: 676–679

    Article  Google Scholar 

  • Kutcher SP, Shulman KI, Reed K (1986 b) Desipramine plasma concentration and therapeutic response in elderly depressives: a naturalistic pilot study. Can J Psychiatry 31: 752–754

    Google Scholar 

  • Livingston RL, Zucker DK, Isenberg K, Wetzel RD (1983) Tricyclic antidepressants and delirium. J Clin Psychiatry 44: 173–176

    PubMed  CAS  Google Scholar 

  • Madakasira S, Khazanie PG (1985) Reliability of amitriptyline dose prediction based on single-dose plasma levels. Clin Pharmacol Ther 37: 145–149

    Article  PubMed  CAS  Google Scholar 

  • Nelson JC, Jatlow P (1980) Neuroleptic effect on desipramine steady state plasma concentrations. Am J Psychiatry 137: 1232–1234

    PubMed  CAS  Google Scholar 

  • Nelson JC, Jatlow PI (1987) Nonlinear desipramine kinetics: prevalence and importance. Clin Pharmacol Ther 41: 666–670

    Article  PubMed  CAS  Google Scholar 

  • Nelson JC, Jatlow PI, Bock J, Quinlan DM, Bowers MB (1982a) Major adverse reactions during desipramine treatment. Arch Gen Psychiatry 39: 1055–1061

    PubMed  CAS  Google Scholar 

  • Nelson JC, Jatlow PI, Quinlan DM, Bowers MB (1982 b) Desipramine plasma concentration and antidepressant response. Arch Gen Psychiatry 39: 1419–1422

    Google Scholar 

  • Nelson JC, Bock J, Jatlow P (1983) The clinical implications of 2-hydroxydesipramine in plasma. Clin Pharmacol Ther 33: 183–189

    Article  PubMed  CAS  Google Scholar 

  • Nelson JC, Jatlow P, Quinlan DM (1984) Subjective side effects during desipramine treatment. Arch Gen Psychiatry 41: 55–59

    PubMed  CAS  Google Scholar 

  • Nelson JC, Jatlow PI, Mazure C (1987) Rapid desipramine dose adjustment using 24-hour levels. J Clin Psychopharmacol 7: 72–77

    PubMed  CAS  Google Scholar 

  • Nelson JC, Mazure C, Jatlow PI (1988a) Antidepressant activity of 2-hydroxy-desipramine. Clin Pharmacol Ther 44: 283–288

    Article  PubMed  CAS  Google Scholar 

  • Nelson JC, Atillasoy E, Mazure C, Jatlow PI (1988b) Hydroxydesipramine in the elderly. J Clin Psychopharmacol 8: 428–433

    Article  PubMed  CAS  Google Scholar 

  • Nies A, Robinson DS, Friedman MJ et al. (1977) Relationship between age and tricyclic antidepressant plasma levels. Am J Psychiatry 134: 790–793

    PubMed  CAS  Google Scholar 

  • Nordin C, Bertilsson L, Siwers B (1985) CSF and plasma levels of nortriptyline and its 10- hydroxy metabolite. Br J Clin Pharmacol 20: 411–413

    PubMed  CAS  Google Scholar 

  • Nordin C, Bertilsson L, Siwers B (1987a) Clinical and biochemical effects during treatment of depression with nortriptyline — the role of 10-hydroxynortriptyline. Clin Pharmacol Ther 42: 10–19

    Article  PubMed  CAS  Google Scholar 

  • Nordin C, Bertilsson L, Otani K et al. (1987b) Little anticholinergic effect of E-10- hydroxynortriptyline compared with nortriptyline in healthy subjects. Clin Pharmacol Ther 41: 97–102

    Article  PubMed  CAS  Google Scholar 

  • Potter WZ, Calil HM, Sutfin TA et al. (1982) Active metabolites of imipramine and desipramine in man. Clin Pharmacol Ther 31: 393–401

    Article  PubMed  CAS  Google Scholar 

  • Preskorn SH, Simpson S (1982) Tricyclic antidepressant induced delirium and plasma drug concentration. Am J Psychiatry 139: 822–823

    PubMed  CAS  Google Scholar 

  • Preskorn SH, Dorey RC, Jerkovich GS (1988) Therapeutic drug monitoring of tricyclic antidepressants. Clin Chem 34: 822–828

    PubMed  CAS  Google Scholar 

  • Quitkin FM et al. (1984) Duration of antidepressant drug treatment. Arch Gen Psychiatry 41: 238–245

    PubMed  CAS  Google Scholar 

  • Robinson DS, Cooper TB, Howard D et al. (1985) Amitriptyline and hydroxylated metabolite plasma levels in depressed outpatients. J Clin Psychopharmacol 5: 83–88

    PubMed  CAS  Google Scholar 

  • Spiker DG, Perei JM, Hanin I et al. (1986) The pharmacological treatment of delusional depression: part II. J Clin Psychopharmacol 6: 339–342

    Article  PubMed  CAS  Google Scholar 

  • Steiner E, Dumont E, Spina E, Dahlqvist R (1987) Inhibition of desipramine 2-hydroxylation by quinidine and quinine. Clin Pharmacol Ther 43: 577–581

    Article  Google Scholar 

  • Stewart JW, Quitkin F, Fyer A, Rifkin A, McGrath P, Liebowitz M, Rosnick L, Klein D (1980) Efficacy of desipramine in endogenously depressed patients. J Affect Dis 2: 165–176

    Article  PubMed  CAS  Google Scholar 

  • Young RC, Alexopoulos GS, Shamoian CA et al. (1984) Plasma 10-hydroxynortriptyline in elderly depressed patients. Clin Pharmacol Ther 35: 540–544

    Article  PubMed  CAS  Google Scholar 

  • Young RC, Alexopoulos GS, Shamoian CA et al. (1985) Plasma 10-hydroxynortriptyline and ECG changes in elderly depressed patients. Am J Psychiatry 142: 866–868

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychiatry, Yale University School of Medicine, 20 York Street, New Haven, CT, 06504, USA

    P. I. Jatlow

  2. Yale-New Haven Hospital, Yale University School of Medicine, 20 York Street, New Haven, CT, 06504, USA

    P. I. Jatlow

Authors
  1. J. C. Nelson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. Mazure
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P. I. Jatlow
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Pharmacology, Institute of Medical Biology, University of Tromsø School of Medicine, 9001, Tromsø, Norway

    Svein G. Dahl (Professor of Pharmacology) (Professor of Pharmacology)

  2. Department of Clinical Pharmacology, School of Medicine, Odense University, 5000, Odense C, Denmark

    Lars F. Gram (Professor of Clinical Pharmacology) (Professor of Clinical Pharmacology)

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Nelson, J.C., Mazure, C., Jatlow, P.I. (1989). Clinical Implications of the Pharmacokinetics of Tricyclic Antidepressants. In: Dahl, S.G., Gram, L.F. (eds) Clinical Pharmacology in Psychiatry. Psychopharmacology Series, vol 7. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-74430-3_24

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-74430-3_24

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-74432-7

  • Online ISBN: 978-3-642-74430-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation